Burden of Cardiovascular Disease in HSCT

CancersCancer inflict the largest burden in the world. Burden of Cancer incidence and mortality is also growing. Hematopoietic stem cell transplantationHematopoietic Stem Cell Transplantation (HSCT) (HSCT) is a curative therapeutic method for malignant hematologic disorders and is associated with early and late treatment related mortality. Cardiac toxicity and cardiovascular consequences are not common in post HSCT patients compared to other HSCTHematopoietic Stem Cell Transplantation (HSCT) related complications. However, these complications play an important role in survivors’ outcome. It is necessary to identify and decrease these life-threatening complications to improve patients’ outcome and decline related cost burden.